QuintilesIMS rebranded as IQVIA

The rebrand is effective immediately and will trade on the NYSE under the new name – ticker symbol IQV – from 15th November.

IQVIA chairman and CEO, Ari Bousbib, said: “Today is a defining moment for our organisation as we introduce a new name that aligns with our vision to help stakeholders drive healthcare forward.

“IMS Health and Quintiles came together because our clients were asking for better, faster ways to bring innovations to patients and capture the improvements the industry has been pursuing for years. Since the merger, we’ve worked to integrate our advanced analytics, leading technologies and therapeutic expertise.”